REBECCA PACE: Open Payments
NPI 1427596568 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,149 in 97 payments from 27 companies in 2025. Trend: 2023 $2,001 · 2024 $1,716 · 2025 $2,149
Food & beverage: $2,149
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $186 |
| Amgen Inc. | 9 | $174 |
| Mannkind Corporation | 11 | $167 |
| Dexcom, Inc. | 3 | $166 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $159 |
| ABBVIE INC. | 9 | $143 |
| CeQur Corporation | 1 | $136 |
| Radius Health, Inc. | 4 | $112 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $99 |
| Xeris Pharmaceuticals, Inc. | 4 | $90 |
Products named: AFREZZA, Dexcom G6 Transmitter, Ozempic, JARDIANCE, CeQur Simplicity, Tymlos, Kerendia, GVOKE HYPOPEN.
Industry payments across VA — which companies pay providers there.
